Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Innate immunity serves as the first line of defence against invading pathogens such as bacteria and viruses. Toll-like receptors (TLRs) are examples of innate immune receptors, which sense specific molecular patterns from pathogens and activate immune responses. TLR9 recognizes bacterial and viral DNA containing the cytosine-phosphate-guanine (CpG) dideoxynucleotide motif. The molecular basis by which CpG-containing DNA (CpG-DNA) elicits immunostimulatory activity via TLR9 remains to be elucidated. Here we show the crystal structures of three forms of TLR9: unliganded, bound to agonistic CpG-DNA, and bound to inhibitory DNA (iDNA). Agonistic-CpG-DNA-bound TLR9 formed a symmetric TLR9-CpG-DNA complex with 2:2 stoichiometry, whereas iDNA-bound TLR9 was a monomer. CpG-DNA was recognized by both protomers in the dimer, in particular by the amino-terminal fragment (LRRNT-LRR10) from one protomer and the carboxy-terminal fragment (LRR20-LRR22) from the other. The iDNA, which formed a stem-loop structure suitable for binding by intramolecular base pairing, bound to the concave surface from LRR2-LRR10. This structure serves as an important basis for improving our understanding of the functional mechanisms of TLR9.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Structural studies recently described two different TLR9i sequences that formed stem-loop structures that fit snugly into the interior of the ring structure of TLR9, preventing dimerization and activation (21).”
From Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses (2021) · cites this paper as [21]
In the citing paper
“the binding site of TLR9i oligonucleotides on TLR9 partially overlapped with that of CpG DNA, and the TLR9i oligonucleotide tested possessed higher binding affinity for TLR9 than CpG DNA”
From Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses (2021) · cites this paper as [21]
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
The PyMOL Molecular Graphics System
DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
PHENIX : building new software for automated crystallographic structure determination
Adams, P. D., Grosse-Kunstleve, R. W., Hung, L.-W., Ioerger, T. R., McCoy, A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K., & Terwilliger, T. C. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902016657 · Cited by 4,361
Schuck, P. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76713-0 · Cited by 3,868
Cited by
Items 101–200 of 381
DNA Transfer and Toll-like Receptor Modulation by Helicobacter pylori
Varga, M. G., & Peek, R. M. (2017) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-50520-6_8 · Cited by 44
“…presence of hypo-methylated CpG DNA motifs (which are rare in eukaryotic genomes); however, accumulating evidence suggests that TLR9 can also recognize DNA in a sequence-independent manner via structural components such as the saccharide backbone (Haas et al. 2008; Wagner 2008; Ohto et al. 2015).”
BackgroundLee, E. Y., Takahashi, T., Curk, T., Dobnikar, J., Gallo, R. L., & Wong, G. C. L. (2017) · ACS Nano · doi:10.1021/acsnano.7b05234 · Cited by 48
Nucleic acids presenting polymer nanomaterials as vaccine adjuvants
Comberlato, A., Paloja, K., & Bastings, M. M. C. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01222b · Cited by 42
Frank, M. J., Khodadoust, M. S., Czerwinski, D. K., Haabeth, O. A. W., Chu, M. P., Miklos, D. B., Advani, R. H., Alizadeh, A. A., Gupta, N. K., Maeda, L. S., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20191712 · Cited by 41
Toll-like receptors in innate immunity and inflammation: from fundamental biology to clinic insights
Qian, C., Cao, X., & Hoffmann, J. A. (2026) · Immunity & Inflammation · doi:10.1007/s44466-026-00040-6 · Cited by 48
Understanding the role of Toll-like receptors in lung cancer immunity and immunotherapy
Hoden, B., DeRubeis, D., Martinez-Moczygemba, M., Ramos, K. S., & Zhang, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1033483 · Cited by 45
Gasser, S., Zhang, W. Y. L., Tan, N. Y., Tripathi, S., Suter, M. A., Chew, Z. H., Khatoo, M., Ngeow, J. Y. Y., & Cheung, F. S. G. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.09.001 · Cited by 46
Miyake, K., Shibata, T., Ohto, U., & Shimizu, T. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.4mr0316-108r · Cited by 39
Self-citationLi, W., Luo, L., Huang, J. L., Wang, Q., Liu, J., Xiao, X., Fang, H., Yang, X., & Wang, K. (2017) · Chemical Communications · doi:10.1039/c7cc01128h · Cited by 37
Wang, A., Dongcheng, C., Zhang, H., Li, Q., Yan, Z., Qiu, Y., Xu, H., & Keji, C. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.02.018 · Cited by 40
Yu, C. H., Bhattacharya, A., Persaud, M., Taylor, A. B., Wang, Z., Bulnes‐Ramos, Á., Xu, J., Selyutina, A., Martínez‐López, A., Cano, K. E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21023-8 · Cited by 36
Dynamic DNA-Based Nanoadjuvants for TLR9 Clustering and Innate Immune Activation in Dendritic Cells
Lv, Z., Guo, X., Zhang, R., Yao, Y., Shao, L., Li, S., Chen, C., Yang, D., & Liu, Y. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c00481 · Cited by 38
Matsushima, N., Miyashita, H., Enkhbayar, P., & Kretsinger, R. H. (2015) · Biomolecules · doi:10.3390/biom5031955 · Cited by 47
Nucleic Acid Sensing in Mammals and Plants: Facts and Caveats
Heil, M., & Vega-Muñoz, I. (2018) · International review of cytology · doi:10.1016/bs.ircmb.2018.10.003 · Cited by 38
Development of nucleic acid medicines based on chemical technology
Kawamoto, Y., Wu, Y., Takahashi, Y., & Takakura, Y. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114872 · Cited by 34
Endosomal Organization of CpG Constructs Correlates with Enhanced Immune Activation
Lee, K., Huang, Z. N., Mirkin, C. A., & Odom, T. W. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c02536 · Cited by 33
Activation of Innate Immunity by Therapeutic Nucleic Acids
Bishani, A., & Chernolovskaya, E. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413360 · Cited by 36
Gene targeting as a therapeutic avenue in diseases mediated by the complement alternative pathway
Dreismann, A. K., Hallam, T. M., Tam, L. C. S., Nguyen, C. V., Hughes, J. P., Ellis, S., & Harris, C. L. (2022) · Immunological Reviews · doi:10.1111/imr.13149 · Cited by 37
The architecture of transmembrane and cytoplasmic juxtamembrane regions of Toll-like receptors
Kornilov, F., Shabalkina, A. V., Lin, C., Volynsky, P. E., Kot, E. F., Kayushin, A. L., Лушпа, В. А., Goncharuk, M. V., Arseniev, A. S., Goncharuk, S. A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37042-6 · Cited by 36
Release of damaged mitochondrial DNA: A novel factor in stimulating inflammatory response
Li, W., Li, Y., Zhao, J., Liao, J., Wen, W., Chen, Y., & Cui, H. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155330 · Cited by 36
Ma, X., Niu, M., Ni, H., & Ding, W. (2026) · Hepatology · doi:10.1097/hep.0000000000000910 · Cited by 46
Algieri, C., Nesci, S., & Oppedisano, F. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07392-4 · Cited by 42
“Among several TLRs, endosomal/extracellular TLR9 is the only receptor for sensing unmethylated cytosine-phosphate-guanine (CpG)-rich DNA, which binds in a sequence-specific manner to the N-terminus of the C-shaped leucine-rich repeat region of TLR9 [69].”
Ngo, Q. V., Faass, L., Sähr, A., Hildebrand, D., Eigenbrod, T., Heeg, K. M., & Nurjadi, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.828626 · Cited by 40
“Degradation of bacterial RNA by heat (95°C for 30 mins) and RNase treatment (60°C for 1 hour) prior to transfection abolished the IL-6 response, whereas DNase treatment had no signi fi cant effect (IL-6 response was not abolished), which suggests that DNA sensing was not responsible for the induction of pro-in fl ammato…”
Patra, M. C., Kwon, H., Batool, M., & Choi, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00489 · Cited by 34
Wang, Z., Ni, X., Zhang, L., Sun, L., Zhu, X., Zhou, Q., Yang, Z., & Yuan, H. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s279104 · Cited by 37
Epstein-Barr virus suppresses N6-methyladenosine modification of TLR9 to promote immune evasion
Zhang, X., Li, Z., Qiu, P., Liu, C., Wu, Y., Wen, Y., Zheng, R., Xu, C., Tian, J., Zheng, X., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107226 · Cited by 39
“TLR9, expressed predominantly in B-cells, is capable of being activated by unmethylated CpG (a motif found in bacterial and viral DNA) to initiate signaling pathways that regulate the production of proin fl ammatory cytokines or interferons (47).”
BackgroundThe Role of Nucleic Acid Sensing in Controlling Microbial and Autoimmune Disorders
Matz, K. M., Guzman, R. M., & Goodman, A. G. (2018) · International review of cytology · doi:10.1016/bs.ircmb.2018.08.002 · Cited by 35
“TLR9 contains a large nonconserved Z-loop between LRR14 and LRR15 that is susceptible to cathepsin-mediated proteolysis.”
BackgroundGuo, H. Y., & Cui, Z. J. (2018) · Cells · doi:10.3390/cells8010003 · Cited by 31
“TLR9, in most cases located intracellularly, is activated by viral and bacterial un-methylated CpG-DNA [37,38], as well as by endogenous mitochondrial DNA from mammalian cells [39].”
BackgroundToll-Like Receptors and Relevant Emerging Therapeutics with Reference to Delivery Methods
Javaid, N., Yasmeen, F., & Choi, S. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11090441 · Cited by 36
“There is a symmetric interaction in the 2:2 stoichiometric ratio between CpG-DNA and TLR9, specifically via the carboxy terminus (LRR20–22) with one protomer and the amino terminus (LRRNT–LRR10) with the other [147].”
BackgroundDongye, Z., Wu, X., Wen, Y., Ding, X., Wang, C., Zhao, T., Li, J., & Wu, Y. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109093 · Cited by 33
Controlled spatial characteristics of ligands on nanoparticles: Determinant of cellular functions
Choi, Y., Cho, B. K., Seok, S. H., Kim, C., Ryu, J. H., & Kwon, I. C. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.07.020 · Cited by 34
Sakakibara, S., Arimori, T., Yamashita, K., Jinzai, H., Motooka, D., Nakamura, S., Li, S., Takeda, K., Katayama, J., Hussien, M. A. E., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16681-y · Cited by 31
Distinctive Recognition of Flagellin by Human and Mouse Toll-Like Receptor 5
Forstnerič, V., Ivičak‐Kocjan, K., Ljubetič, A., Jerala, R., & Benčina, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158894 · Cited by 32
Membrane TLR9 Positive Neutrophil Mediated MPLA Protects Against Fatal Bacterial Sepsis
Yang, Z., Wang, L., Yu, H., Wang, R., Gou, Y., Zhang, M., Chen, K., Liu, T., Lan, Y., Wang, X., et al. (2019) · Theranostics · doi:10.7150/thno.37139 · Cited by 29
“Given that TLRs translocation to the plasma membrane can occur under stimulated conditions [19-23], we hypothesized that a similar translocation event may happen with TLR9 in the setting of InP.”
BackgroundKundu, B., Raychaudhuri, D., Mukherjee, A., Sinha, B. P., Sarkar, D., Bandopadhyay, P., Pal, S., Das, N., Dey, D., Ramarao, K., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00532 · Cited by 30
Computational Discovery and Experimental Confirmation of TLR9 Receptor Antagonist Leads
Zatsepin, M., Mattes, A., Rupp, S., Finkelmeier, D., Basu, A., Burger‐Kentischer, A., & Goldblum, A. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00070 · Cited by 30
“TLR9 structures from horse and mouse sources were published only after the termination of this work, including complexes with DNA fragments as agonists and antagonists.(27) We studied those structures and attempted to test them for docking at the request of a reviewer.”
BackgroundThe role of protein–protein interactions in Toll-like receptor function
Berglund, N. A., Kargas, V. E., Ortiz-Suarez, M. L., & Bond, P. J. (2015) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2015.06.021 · Cited by 35
“TLR7 and TLR8 bind single stranded RNA, whilst TLR9 recognizes unmethylated CpG DNA, a form of DNA rarely found in vertebrates but commonly associated with viral and bacterial genomes [15,19] (Figs 1F, G).”
BackgroundInfluentialCpG incorporated DNA microparticles for elevated immune stimulation for antigen presenting cells
Jung, H., Kim, D., Kang, Y. Y., Kim, H., Lee, J. B., & Mok, H. (2018) · RSC Advances · doi:10.1039/c7ra13293j · Cited by 28
The role of extracellular DNA in COVID-19: Clues from inflamm-aging
Storci, G., Bonifazi, F., Garagnani, P., Olivieri, F., & Bonafè, M. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101234 · Cited by 32
Selective evolution of Toll-like receptors 3, 7, 8, and 9 in bats
Jiang, H., Li, J., Li, L., Zhang, X., Yuan, L., & Chen, J. (2016) · Immunogenetics · doi:10.1007/s00251-016-0966-2 · Cited by 35
“The maximum likelihood (ML) trees were generated based on the codon sequences by PhyML 3.0 (Guindon et al. 2010) with 1000 bootstraps.”
MethodInfluentialFehér, K. (2019) · Current Protein and Peptide Science · doi:10.2174/1389203720666190830162149 · Cited by 28
Modulation of Toll-like receptor 1 intracellular domain structure and activity by Zn2+ ions
Лушпа, В. А., Goncharuk, M. V., Lin, C., Zalevsky, A. O., Talyzina, I. A., Luginina, A. P., Vakhrameev, D. D., Shevtsov, M. B., Goncharuk, S. A., Arseniev, A. S., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02532-0 · Cited by 30
Helicobacter pylori Pathogen-Associated Molecular Patterns: Friends or Foes?
Eletto, D., Mentucci, F. M., Voli, A., Petrella, A., Porta, A., & Tosco, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073531 · Cited by 35
“TLR9 was initially reported to recognize pathogenic DNAs based upon the presence of hypo-methylated CpG DNA motifs; however, accumulating evidence suggests that TLR9 can also detect DNA in a sequence-independent manner by recognition of the saccharide backbone [64,65].”
BackgroundShen, Y., Chen, L., Chen, J., Qin, J., Wang, T., & Wen, F. (2022) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2022-0019 · Cited by 28
“[34,35] An animal study reported that intratracheal administration of mitochondrial DNA could induce lung inflammatory response in mice, which was through the interaction with TLR9 and related MAPK signaling transduction pathway.”
BackgroundTanegashima, K., Takahashi, R., Nuriya, H., Iwase, R., Naruse, N., Tsuji, K., Shigenaga, A., Otaka, A., & Hara, T. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.09.012 · Cited by 29
Pollak, A. J., Zhao, L., & Crooke, S. T. (2023) · Nucleic Acid Therapeutics · doi:10.1089/nat.2022.0067 · Cited by 27
“We determined that this is likely due to the complex nature of the interactions between PS-ASOs and TLR9 (which has multiple ASO binding sites [17–19]), yet the exact details of this phenomenon remain unknown.”
The role of bacterial DNA containing CpG motifs in diseases
Zhou, J., & Deng, G. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr1220-748rrrrr · Cited by 30
Small molecule modulators of immune pattern recognition receptors
Tsukidate, T., Hespen, C. W., & Hang, H. C. (2023) · RSC Chemical Biology · doi:10.1039/d3cb00096f · Cited by 28
The potential role of retroviruses in autoimmunity
Yu, P. (2015) · Immunological Reviews · doi:10.1111/imr.12371 · Cited by 29
Yu, D., Wu, Y., Xu, L., Fan, Y., Peng, L., Xu, M., & Yao, Y. (2016) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2016.02.025 · Cited by 27
Murakami, Y., Fukui, R., Motoi, Y., Shibata, T., Saitoh, S.-I., Sato, R., & Miyake, K. (2017) · Scientific Reports · doi:10.1038/srep44042 · Cited by 27
Self-citationCleavage of Toll-Like Receptor 9 Ectodomain Is Required for In Vivo Responses to Single Strand DNA
Fukui, R., Yamamoto, C., Matsumoto, F., Onji, M., Shibata, T., Murakami, Y., Kanno, A., Hayashi, T., Tanimura, N., Yoshida, N., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01491 · Cited by 27
“Recently, the structure of TLR9 complexed with ssDNA has been reported (14).”
BackgroundSelf-citationThe role of toll‐like receptors in immune tolerance induced by Helicobacter pylori infection
Zhang, X., Zhang, K., Yan, L., Wang, P., Zhao, F., & Hu, S. (2023) · Helicobacter · doi:10.1111/hel.13020 · Cited by 25
“38,81,82 In the Brazilian population, TLR9 polymorphisms influence the risk of gastric carcinogenesis.”
BackgroundGogate, A., Belcourt, J., Shah, M., Wang, A., Frankel, A., Kolmel, H., Chalon, M., Stephen, P., Kolli, A., Tawfik, S. M., et al. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.123.000815 · Cited by 28
Structural and evolutionary characteristics of fish-specific TLR19
Wang, J., Zhang, Z., Fu, H., Zhang, S., Liu, J., Chang, F., Li, F., Zhao, J., & Yin, D. (2015) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2015.09.005 · Cited by 25
Structural aspects of nucleic acid-sensing Toll-like receptors
Ohto, U., & Shimizu, T. (2016) · Biophysical Reviews · doi:10.1007/s12551-015-0187-1 · Cited by 28
Self-citationTargeting the innate immune receptor TLR8 using small-molecule agents
Sakaniwa, K., & Shimizu, T. (2020) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798320006518 · Cited by 26
“…the structural and molecular basis for the antagonistic mechanism of the oligonucleotide for TLR7/8 was unknown, although the inhibition mechanism of TLR9 and the activation mechanism of TLR7/8/9 by nucleoside sensing have been reported (Ohto et al., 2015; Tanji et al., 2015; Zhang et al., 2016).”
BackgroundSelf-citationStructural basis for species‐specific activation of mouse Toll‐like receptor 9
Ishida, H., Ohto, U., Shibata, T., Miyake, K., & Shimizu, T. (2018) · FEBS Letters · doi:10.1002/1873-3468.13176 · Cited by 23
Self-citationToll‐like receptor 2 antagonists identified through virtual screening and experimental validation
Durai, P., Shin, H., Achek, A., Kwon, H., Govindaraj, R. G., Panneerselvam, S., Yesudhas, D., Choi, J., No, K. T., & Choi, S. (2017) · FEBS Journal · doi:10.1111/febs.14124 · Cited by 24
Lee, M. W., Lee, E. Y., Ferguson, A. L., & Wong, G. C. L. (2018) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2018.11.003 · Cited by 22
Monomeric G-Quadruplex-Based CpG Oligodeoxynucleotides as Potent Toll-Like Receptor 9 Agonists.
Tu, A. T. T., Hoshi, K., Ikebukuro, K., Hanagata, N., & Yamazaki, T. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c00679 · Cited by 18
Host-pathogen protein-nucleic acid interactions: A comprehensive review
Jain, A., Mittal, S., Tripathi, L. P., Nussinov, R., & Ahmad, S. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.08.001 · Cited by 23
“Notably, TLR9 primarily recognizes the hexamer consensus sequence of ssDNA [104].”
BackgroundImmunomodulation with Nucleic Acid Nanodevices
Ding, F., Zhang, S., Chen, Q., Feng, H., Ge, Z., Zuo, X., Fan, C., Li, Q., & Xia, Q. (2023) · Small · doi:10.1002/smll.202206228 · Cited by 23
The transcriptional repressor Gfi1 prevents lupus autoimmunity by restraining TLR7 signaling
Desnues, B., Macedo, A. B., Ordoñez‐Rueda, D., Roussel‐Queval, A., MALISSEN, B., Bruhns, P., Malissen, M., & Alexopoulou, L. (2016) · European Journal of Immunology · doi:10.1002/eji.201646573 · Cited by 21
Activity-guided development of potent and selective toll-like receptor 9 antagonists
Paul, B., Rahaman, O., Roy, S., Pal, S., Satish, S., Mukherjee, A., Ghosh, A. R., Raychaudhuri, D., Bhattacharya, R., Goon, S., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.09.058 · Cited by 21
Unlocking the Potential of Chemically Modified Nucleic Acid Therapeutics
Gao, J., Nutan, B., Gargouri, D., Pisal, N. D., Do, V., Zubair, M., Alanzi, H., Wang, H., Lee, D., Joshi, N., et al. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202400231 · Cited by 25
Yoshida, T., Hagihara, T., Uchida, Y., Horiuchi, Y., Sasaki, K., Yamamoto, T., Yamashita, T., Goda, Y., Saito, Y., Yamaguchi, T., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-61666-3 · Cited by 23
“…the crystal structure of TLR9 in complex with a 6-mer ODN containing a 5 ′ -xCx motif and a 10-mer ODN with a central CpG motif, Ohto et al. demonstrated that the 5 ′ -xCx and CpG motifs bind to distinct sites on TLR9 and cooperatively drive dimerization and subsequent activation of TLR9 23,28 .”
BackgroundDesigning an immunocyte-targeting delivery system by use of beta-glucan
Miyamoto, N., Mochizuki, S., & Sakurai, K. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.11.053 · Cited by 22
Yang, L. S., Lang, Y., Wu, H., Xiang, K., Wang, Y., Yu, M., Liu, Y., Yang, B., He, L., Lu, G., et al. (2023) · ACS Nano · doi:10.1021/acsnano.2c08429 · Cited by 20
O’Donovan, D. H., Mao, Y., & Mele, D. A. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190620103105 · Cited by 21
Evolution of toll-like receptor gene family in amphibians
Zhang, L., Liu, G., Xia, T., Yang, X., Sun, G., Zhao, C., Xu, C., & Zhang, H. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.03.112 · Cited by 19
Discovery of Novel Small Molecule Dual Inhibitor Targeting Toll-Like Receptors 7 and 9
Haseeb, M., Choi, Y. S., Patra, M. C., Jeong, U., Lee, W. H., Qayyum, N., Choi, H., Kim, W., & Choi, S. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c00578 · Cited by 20
Blocking TIR Domain Interactions in TLR9 Signaling
Javmen, A., Szmacinski, H., Lakowicz, J. R., & Toshchakov, V. Y. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800194 · Cited by 18
“Evaluation of cytokine expression by quantitative real time PCR BMDM (2 3 106 per well) were plated in 12-well plates, incubated overnight, and treated with CPDPs for 30 min. cDNA was synthesized from 1 mg of total RNA isolated using Trizol (Life Technologies, Carlsbad, CA) and reverse transcribed using RevertAid RT R…”
BackgroundInfluentialWu, J., Su, W., Powner, M. B., Liu, J., Copland, D. A., Fruttiger, M., Madeddu, P. R., Dick, A. D., & Liu, L. (2016) · Scientific Reports · doi:10.1038/srep31873 · Cited by 18
Pohar, J., Lainšček, D., Kunšek, A., Cajnko, M. M., Jerala, R., & Benčina, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-15178-y · Cited by 20
Toll-like receptor bioactivity in endothelial progenitor cells
Heidarzadeh, M., Roodbari, F., Hassanpour, M., Ahmadi, M., Saberianpour, S., & Rahbarghazi, R. (2019) · Cell and Tissue Research · doi:10.1007/s00441-019-03119-2 · Cited by 18
Coevolutionary Analysis Implicates Toll-Like Receptor 9 in Papillomavirus Restriction
King, K. M., Larsen, B. B., Gryseels, S., Richet, C., Kraberger, S. J., Jackson, R., Worobey, M., Harrison, J. S., Varsani, A., & Doorslaer, K. V. (2022) · mBio · doi:10.1128/mbio.00054-22 · Cited by 15
Das, N., Bandopadhyay, P., Roy, S., Sinha, B. P., Dastidar, U. G., Rahaman, O., Pal, S., Ganguly, D., & Talukdar, A. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00386 · Cited by 17
Tarashima, N. S., Ando, H., Kojima, T., Kinjo, N., Hashimoto, Y., Furukawa, K., Ishida, T., & Minakawa, N. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.48 · Cited by 17
Complex Negative Regulation of TLR9 by Multiple Proteolytic Cleavage Events
Sinha, S., Cameron, J. L., Brooks, J. C., & Leifer, C. A. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502357 · Cited by 18
Durojaye, O. A., Sedzro, D. M., Idris, M. O., Yekeen, A. A., Fadahunsi, A. A., & Alakanse, O. S. (2022) · ChemistrySelect · doi:10.1002/slct.202103903 · Cited by 17
Mitochondrial DNA in Exercise-Mediated Innate Immune Responses
Wen, X., Fan, J., Duan, X., Zhu, X., Bai, J., & Zhang, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073069 · Cited by 20
“In 2010, Hauser(cid:31)s lab fi rst reported that the CpG sequence of mtDNA could activate TLR9, which in turn activated the neutrophil mitogen-activated protein kinase (MAPK) signaling pathway [39,40]. of TLR9 [42].”
RNA polymerase III and antiviral innate immune response
Jarrous, N., & Rouvinski, A. (2021) · Transcription · doi:10.1080/21541264.2021.1890915 · Cited by 17
Cacace, R., Zhou, L., de Craen, E. H. V., Buist, A., Hoogmartens, J., Sieben, A., Cras, P. P., Vandenberghe, R. R., Deyn, P. P. D., Oehlrich, D., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02166-0 · Cited by 16
“10).”
BackgroundHovhannisyan, G. G., Harutyunyan, T. A., Aroutiounian, R. M., & Liehr, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814163 · Cited by 16
“Suppressive synthetic oligodeoxynucleotides (ODNs), composed entirely of TTAGGG multimers, effectively down-regulate CpG-induced immune activation in a mouse model [132].”
BackgroundToll-like receptor-targeted nanoparticles: A powerful combination for tumor immunotherapy
Zhi, X., Yang, P., Xu, Y., Dai, Z., Yue, X., & Qian, L. (2023) · Nano Today · doi:10.1016/j.nantod.2023.102003 · Cited by 20
Design and development of benzoxazole derivatives with toll-like receptor 9 antagonism
Roy, S., Mukherjee, A., Paul, B., Rahaman, O., Roy, S., Maithri, G., Ramya, B., Pal, S., Ganguly, D., & Talukdar, A. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.03.086 · Cited by 17
Imasaki, T., Wenzel, S., Yamada, K., Bryant, M. L., & Takagi, Y. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195356 · Cited by 16
New insights into the role of IFN-α/β and TLR7/8/9 in cancer immunotherapy and systemic autoimmunity
Krieg, A. Μ. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-012165 · Cited by 18
MASTer cell: chief immune modulator and inductor of antimicrobial immune response
Vázquez, T. A. S., López‐López, N., & Salinas-Carmona, M. C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1360296 · Cited by 20
“…TLR2 that recognizes peptidoglycan, zymosan, and some types of lipopolysaccharide (LPS) (48, 49); TLR3 that binds to double-stranded RNA (50); TLR4 that is activated by LPS (49); TLR6 that binds to peptidoglycan and zymosan (53); and TLR9 that recognizes bacterial DNA and CpG-containing DNA (54).”
BackgroundInfluentialExtension and refinement of the recognition motif for Toll-like receptor 5 activation by flagellin
Ivičak‐Kocjan, K., Forstnerič, V., Panter, G., Jerala, R., & Benčina, M. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3vma0118-035r · Cited by 15
Hussain, M., Ijaz, M. U., Ahmad, M. I., Khan, I. A., Bokhary, S. U. F., Khan, W., Hussain, S., Hashmi, M. S., & Li, C. (2020) · Food & Function · doi:10.1039/d0fo02153a · Cited by 17
The Mutual Relation of Platelet Activation and Innate Immunity
Eisinger, F., & Langer, H. F. (2018) · Hämostaseologie · doi:10.1055/s-0038-1669450 · Cited by 17
Modulating Immune Response with Nucleic Acid Nanoparticles
Durbin, J. K., Miller, D. K., Niekamp, J., & Khisamutdinov, E. F. (2019) · Molecules · doi:10.3390/molecules24203740 · Cited by 15
Nagaoka, M., Liao, W., Kusamori, K., & Nishikawa, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031350 · Cited by 14
Designing a multi-epitope influenza vaccine: an immunoinformatics approach
Momajadi, L., Khanahmad, H., & Mahnam, K. (2024) · Scientific Reports · doi:10.1038/s41598-024-74438-w · Cited by 18
“TLR9 identifies ssDNA comprising the CpG motif, and the active form of TLR9 is the TLR9 dimer 60–63 .”
BackgroundDolina, J. S., Lee, J., Griswold, R. Q., Labarta-Bajo, L., Kannan, S., Greenbaum, J., Idrissi, N. B. E., Pont, M. J., Croft, M., & Schoenberger, S. P. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.040 · Cited by 15
“TLR9 is an endosomal PRR capable of recognizing naturally derived cytosine-phosphate-guanine (CpG) oligodeoxynucleotides (ODNs) in a 2:2 stoichiometry (Ohto et al., 2015).”
Ohto, U. (2017) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c17-00323 · Cited by 14
Self-citationFine tuning of CpG spatial distribution with DNA origami for improved therapeutic cancer vaccinationPreprint
Zeng, Y. C., Young, O. J., Wintersinger, C. M., Anastassacos, F. M., MacDonald, J. I., Isinelli, G., Dellacherie, M. O., Sobral, M. C., Bai, H., Graveline, A. R., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.08.495340 · Cited by 14
Matziol, T., Talagayev, V., Weindl, G., & Wolber, G. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104495 · Cited by 17
Metadata
- Authors
- Ohto, U., Shibata, T., Tanji, H., Ishida, H., Krayukhina, E., Uchiyama, S., Miyake, K., & Shimizu, T.
- Affiliations
- The University of Tokyo (JP)
- Japan Science and Technology Agency (JP)
- The University of Osaka (JP)
- Institute of Medical Science, The University of Tokyo (JP)
- Corresponding author
- Shimizu, Toshiyuki
- Venue
- Nature
- Published
- 2015-02-09
- Volume
- 520
- Issue
- 7549
- Pages
- 702-705
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2129961630
- Semantic Scholar
- 385253b727f67c70b401c7d39f56cdcb8ddf5dc1
- Cited by
- 377
- References
- 34
- Citations by year
- 2026: 30 · 2025: 30 · 2024: 32 · 2023: 36 · 2022: 33 · 2021: 31 · 2020: 33 · 2019: 28 · 2018: 36 · 2017: 30 · 2016: 43 · 2015: 15
- FWCI
- 20.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Japan Society for the Promotion of Science (25121722, 25253032, 25291010)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- TLR9, CpG DNA, innate immunity, TLR9 activation, crystal structure, ligand binding, leucine-rich repeats, stem-loop structure, intramolecular base pairing
- MeSH terms
- Animals, Base Sequence, DNA, Humans, Ligands, Models, Molecular, Nucleic Acid Conformation, Structure-Activity Relationship, Protein Structure, Tertiary, Crystallography, X-Ray, CpG Islands, Toll-Like Receptor 9
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.